Introduction
CNA Financial Corporation (NYSE: CNA) is a Chicago-based commercial property and casualty (P&C) insurance company that is majority-owned by Loews Corporation ([1]). Loews holds roughly a 92% stake in CNA, leaving a limited public float and tightly aligned ownership structure ([1]). With over 120 years of operating history, CNA is one of the largest U.S. commercial P&C insurers, offering a broad range of standard and specialty insurance products for businesses and professionals across the U.S., Canada, and Europe ([2]). In recent years CNA has delivered steady underwriting profits and growing investment income, supporting a generous dividend policy for shareholders. This report provides a deep dive into CNA’s financial profile – covering its dividend history and yield, capital structure and debt maturities, earnings coverage, valuation, and key risks – all grounded in reputable sources.
Dividend Policy & Yield
CNA has a shareholder-friendly dividend policy characterized by a steady baseline payout augmented by periodic special dividends. The regular quarterly dividend has been increased by about 5% annually in recent years – for example, rising from $0.40 per share in early 2022 to $0.42 in 2023, $0.44 in 2024, and most recently $0.46 per share (declared for early 2025) ([3]) ([4]). These consistent raises reflect management’s confidence in stable earnings. At the current quarterly rate ($0.46), CNA’s indicated annualized regular dividend is $1.84 per share, which equates to a dividend yield of approximately 3.9% at recent stock prices ([5]). This yield is notably higher than many peers in the P&C insurance industry, underscoring CNA’s robust cash generation and shareholder return focus.
In addition to the regular dividend, CNA frequently pays special dividends that meaningfully boost total yield. In early 2024, the board declared a $2.00 per share special dividend (paid in March 2024, alongside the $0.44 quarterly payout) ([6]). Again in early 2025, CNA announced another $2.00 special dividend in conjunction with its Q4 2024 results ([4]). This pattern of extra payouts also occurred in prior years – for instance, a $1.20 special dividend was paid in early 2023 (after 2022 results) ([3]), and a $2.00 special in early 2022 (after 2021 results) ([7]). These one-time dividends have become a recurring feature, effectively returning excess capital to shareholders when performance allows. Including specials, CNA’s trailing twelve-month total dividends were $3.76 per share in 2024 ([8]), which is roughly double the base dividend and would imply a very high effective yield (over 8% on the recent share price). It’s important to note that such special distributions, while generous, are not guaranteed every year and depend on earnings and capital needs.
Dividend coverage appears solid. Excluding special bonuses, the regular dividend consumes a moderate portion of earnings, leaving ample buffer. For example, CNA’s core income was about $4.83 per share in 2024 ([4]), while the regular dividends paid in 2024 totaled $1.76 per share – a payout ratio of roughly 36%. Even including the $2 special (total $3.76 paid), the payout was about 78% of core earnings ([8]). In other words, CNA’s ordinary dividend is well-covered by recurring profits, and the company only distributes the additional special dividend when excess capital permits. Indeed, management’s willingness to pay large specials highlights CNA’s strong capital position and cash flow. However, investors should be aware that in quarters when a special dividend is paid, the payout ratio will spike temporarily – for instance, the Q1 2025 dividend (regular + special) amounted to 246% of that quarter’s earnings per share ([9]) ([9]). This reflects a one-time return of capital; excluding the special, dividend payouts are much more sustainable (about 46% of quarterly EPS in that example). Going forward, the baseline dividend increases signal confidence, but the continuation of special dividends will depend on surplus capital and favorable results, which warrants monitoring each year.
Leverage & Debt Maturities
CNA’s balance sheet leverage is moderate and its debt maturity profile is well-distributed, contributing to a conservative financial posture. As of mid-2025, the company’s debt-to-equity ratio is around 0.26 (26%), indicating that debt is about one-quarter of total capital – a relatively low leverage level for an insurer ([10]). This corresponds to a capital structure primarily funded by equity, which provides cushion for the company’s underwriting risks and financial flexibility. Credit ratings agencies have noted that CNA’s risk-adjusted capitalization remains strong, even considering some decline in GAAP equity from bond market swings ([11]).
In absolute terms, CNA carries approximately $3.0 billion of long-term debt on its books ([8]). Importantly, there are no significant debt maturities until 2026, as the company recently refinanced or repaid nearer-term obligations. In 2023 and 2024, CNA executed debt issuance and repayment transactions to push out its maturity schedule: it issued $500 million of new senior notes due 2033 (at 5.50% interest) and another $500 million due 2034 (5.125%), using proceeds to retire a $243 million debenture that matured in Nov 2023 and a $550 million note that matured in May 2024 ([8]). After these moves, the next maturity is a $500 million, 4.50% note due March 1, 2026, followed by a $500 million note due 2027, and additional $500 million tranches in 2029, 2030, 2033, and 2034 ([8]). This laddered schedule (essentially one $500M maturity every couple of years after 2026) reduces refinancing risk and avoids any single large near-term wall of debt.
CNA’s interest expense is relatively small in the context of its earnings – interest costs were about $133 million in 2024 ([8]). Given that full-year core operating income exceeded $1.3 billion ([4]), the company’s EBITDA/interest or earnings coverage of interest is roughly on the order of 10× or more. This strong interest coverage suggests that CNA can comfortably meet its debt service obligations out of operating profits, and it has ample liquidity if needed. The company maintains a $250 million revolving credit facility as additional back-up liquidity (unused as of the latest report) ([8]), though it has not needed to draw on it. Overall, CNA’s leverage and debt maturity outlook appear prudent and well-managed, with limited refinancing risk in the short term and a cost of debt that is manageable relative to income. This conservative leverage supports the firm’s capacity to continue paying dividends and weathering insurance losses or investment volatility.
Earnings Coverage & Financial Strength
CNA’s operating performance has been robust, providing solid coverage for both its financial obligations and shareholder distributions. On the underwriting side, the company has achieved profitable combined ratios and steady premium growth, which underpin its earnings power. In 2024, CNA’s P&C operations delivered a 94.9% combined ratio (meaning $0.949 in claims and expenses for each $1 of premium), indicating an underwriting profit margin ([4]). Excluding catastrophe losses, the underlying combined ratio was even better (around 91-92%), reflecting disciplined risk selection and rate increases. Notably, during the third quarter of 2024 – a period marked by elevated industry catastrophe losses – CNA still grew premiums (to $2.59 billion, from $2.41 billion in the prior-year quarter) and posted an underlying P&C combined ratio of 91.6%, highlighting strong core underwriting results ([12]). This consistent performance suggests that CNA’s regular earnings can comfortably fund its normal dividend. Indeed, the regular dividend payout has generally been under 40% of core earnings, leaving a sizable buffer for reinvestment or special payouts.
On the investment side, rising interest rates have meaningfully boosted CNA’s net investment income, which is a key component of earnings coverage. Loews (CNA’s parent) reported that CNA’s investment income jumped to $776 million in Q3 2024 (from $592 million a year prior) ([12]), thanks to higher yields on the bond portfolio and alternative investments. Higher investment income directly improves CNA’s coverage ratios – it increases earnings and cash flow available to pay interest, claims, and dividends. However, it’s worth mentioning that rising rates also caused mark-to-market losses on CNA’s fixed-income portfolio in 2022, which reduced GAAP book value (as bond prices fell) ([11]). These unrealized losses (reflected in Accumulated Other Comprehensive Income (AOCI)) don’t affect regulatory capital or core operating income, but rating agencies have noted the drop in GAAP equity as a partial concern ([11]). Encouragingly, CNA’s statutory capital remains strong – for instance, its long-term care reserves have a positive margin (surplus of statutory reserves over best-estimate liabilities) that actually grew to $1.4 billion in 2024 with higher reinvestment yields ([8]) ([8]). This indicates that rising rates, on balance, have improved the outlook for funding long-tailed liabilities like long-term care.
3 Stocks to Own Before Oct 16
The payment rails, the mint, and the platform — the three plays that could define America’s new money.
From a dividend coverage perspective, CNA’s operating cash flow comfortably funds its routine dividends, and even with special dividends the company has managed distributions without straining liquidity. In 2024, CNA paid out about $1.025 billion in total dividends (mostly to its majority owner, Loews) ([8]), yet still ended the year with a strong capital position. The ability to upstream large dividends from insurance subsidiaries is subject to regulatory limits, but CNA’s insurance units generated sufficient earnings to allow $995 million of dividends up to the holding company in 2024 ([8]). This internal capital generation is a positive sign for dividend sustainability. Moreover, interest coverage remains high – as noted, pre-tax earnings are roughly ten times annual interest expense, indicating that debt obligations do not impinge on CNA’s capacity to pay dividends or claims. Overall, CNA’s financial strength – supported by solid underwriting profitability and increasing investment income – provides a healthy coverage cushion for both creditors and shareholders. The main challenge will be maintaining this performance through market cycles (insurance pricing and investment yields), which we discuss in the risk section.
Valuation & Peer Comparison
In the equity market, CNA’s stock appears to trade at conservative valuation multiples relative to its fundamentals, perhaps reflecting its unique ownership structure and lower liquidity. CNA shares recently traded around the mid-$40s per share, which is roughly equal to the company’s book value (shareholders’ equity) excluding AOCI. At year-end 2024, CNA’s book value per share excluding unrealized investment losses was about $46.16 ([4]), and the stock has hovered near that level, implying a Price-to-Book (P/B) ratio of about 1.0×. Many comparable P&C insurers trade at higher multiples of book value – for example, large peers like Chubb or Travelers often command 1.3–1.5× book when adjusted for AOCI – reflecting perhaps stronger growth or simply market premiums. CNA’s roughly book-value valuation suggests the market might be applying a discount, potentially due to its majority-owner overhang (Loews) or concerns about its lower growth segments (like run-off long-term care).
In terms of earnings, CNA’s Price-to-Earnings (P/E) ratio is in the single digits. Based on forward earnings estimates, the stock trades around 9–10× forward earnings ([13]), which is on the low end for the insurance sector. The trailing P/E (using 2024 net income of $3.52 per share ([4])) is a bit higher, roughly 13×, but if one uses core (operating) earnings of $4.83 per share ([4]), the multiple is under 10×. In contrast, many P&C insurance stocks trade in the low teens P/E range. CNA’s dividend yield (around 4% on regular dividends alone, or potentially ~8% including recent specials) is substantially higher than the typical peer yield of 2–3%. This high yield, coupled with a low P/E, can indicate the stock is undervalued – or it may reflect caution about future growth or one-time earnings components.
One factor in valuation is Loews Corporation’s ownership of CNA. With Loews owning ~92%, CNA has a very small public float and limited analyst coverage, which can lead to less trading liquidity and potentially a pricing discount. Minority investors have little influence, and there is virtually no chance of a takeover or activist involvement given Loews’ control. While Loews’ stewardship provides stability (and Loews benefits from CNA’s dividends directly), some investors may demand a valuation discount for the lack of control and low float. On the other hand, Loews’ support can be seen as a strength: AM Best explicitly notes the “implicit and explicit support” from Loews as a positive credit factor for CNA ([11]). If we compare fundamentals, CNA’s returns on equity (ROE) have been in the high single digits to low double digits (core ROE was roughly 10.5% in 2024 on average equity excluding AOCI ([4])). This is respectable, though not industry-leading, which may partially explain a valuation around book value. In summary, CNA’s stock valuation is modest, with metrics like ~1.0× book and ~9–10× forward earnings indicating a possibly underappreciated equity. Investors are essentially getting a 4% yield for a well-capitalized insurer, plus potential upside if specials continue. The key for valuation improvement would be continued earnings growth or a change in market perception – which could hinge on the risk factors and open questions discussed next.
Key Risks and Red Flags
Despite its strengths, CNA faces several risks and potential red flags that investors should keep in mind:
– Catastrophe and Underwriting Risk: As a P&C insurer, CNA is exposed to losses from catastrophic events (hurricanes, wildfires, etc.) and adverse claims experience. Elevated catastrophe activity could cause quarterly earnings volatility or even underwriting losses. For instance, in 2024 the industry saw substantial hurricane losses (e.g., Hurricane Milton), though CNA managed to withstand these with only modest impact ([12]). Nevertheless, a severe catastrophe season or unexpected surge in claims (e.g. due to “social inflation” increasing litigation costs) could weaken CNA’s combined ratio and profitability. The company mitigates this through reinsurance and disciplined underwriting, but this risk is inherent to its business.
– Reserve Adequacy (Long-Tail Liabilities): CNA has long-tail lines of business, notably the legacy long-term care (LTC) insurance book in run-off, as well as long-tail casualty exposures (e.g., general liability, professional liability, and older asbestos/environmental claims). In the past, CNA has taken charges related to these lines. AM Best has pointed out that the discontinued LTC program continues to be a drag on results at times ([11]). There is a risk that reserves for LTC or other long-tail claims may prove insufficient if claim trends worsen (for example, if policyholders live longer or require more care in the LTC block). While CNA’s actuarial best estimates currently show a positive margin in LTC reserves ([8]) ([8]), this assumes certain interest rate and morbidity trends – any adverse deviation could necessitate strengthening reserves, which would hurt earnings. Investors should watch for reserve development in long-tail segments as a potential red flag.
– Investment Portfolio Volatility: CNA’s $45+ billion investment portfolio (mostly fixed-income securities supporting its insurance reserves) is subject to market risk. Rising interest rates have two opposite effects: they increase future investment income (a positive), but they cause unrealized losses on existing bond holdings. In 2022, CNA’s GAAP equity fell significantly due to mark-to-market losses on its bond portfolio as interest rates spiked ([11]). While CNA doesn’t have to realize these losses if it holds bonds to maturity, and statutory capital wasn’t impacted as severely, a similar rapid rise in rates or a credit market downturn could again hit the balance sheet. Additionally, any exposure to riskier assets (equities, limited partnership investments, etc.) introduces market volatility. The company’s overall investment strategy is fairly conservative (with high-quality bonds), but in a downturn, declining portfolio values or impaired investments are a risk to watch.
– Regulatory and Capital Constraints: CNA’s insurance subsidiaries are regulated by state insurance departments, which impose capital and dividend restrictions. Upstreaming dividends from the insurance companies to the holding company is limited to formula-driven amounts each year (generally a percentage of surplus or prior-year income) ([8]). If CNA were to suffer large losses, regulators could restrict dividends to preserve capital, which would directly affect the holding company’s ability to pay the CNA corporate dividend. Thus far, CNA has had ample statutory capacity (as evidenced by nearly $1 billion of sub dividends in 2024 ([8])), but this could change under stress scenarios. Regulatory changes (e.g., higher capital charges or reserve requirements) are another potential concern, albeit not a current issue.
– Majority Ownership and Governance: While Loews’ 92% ownership provides stability, it also means minority shareholders have virtually no say in corporate decisions. There is a theoretical risk that Loews could prioritize its own interests over minority shareholders – for example, by influencing CNA to take actions benefiting Loews (though any such actions would also affect Loews as the dominant owner of CNA). Thus far, Loews has treated CNA’s minority shareholders pro rata – dividends are shared equally and no differential treatment has been evident. However, one governance red flag is the lack of liquidity and low public float; this can lead to stock price inefficiency and might deter some investors. Additionally, Loews could decide at some point to buy in or sell its stake, which could create event risk (positive or negative for minorities depending on terms).
– Management Transitions and Execution: In 2024, CNA announced a leadership transition – long-time CEO Dino Robusto stepped down, and Doug Worman (formerly EVP and underwriting head) was appointed CEO effective January 1, 2025 ([14]). Such transitions can carry execution risk: while Worman is experienced in underwriting, investors will watch whether the strategic direction remains consistent and whether performance continues under new leadership. Robusto had led CNA to improved profitability over his tenure ([14]); any shift in risk appetite or missteps by new management could be a concern. Thus far, the transition appears orderly (Robusto moved to Executive Chairman during 2024 ([14])), but it’s an area to monitor.
– Other Red Flags: CNA has experienced isolated issues such as a large cybersecurity incident in 2021 (ransomware attack) that disrupted operations and reportedly led to a significant payment to resolve ([15]). While that event was one-time and CNA likely enhanced its cyber defenses afterward, it highlights operational risks for a financial institution. Additionally, competitive dynamics in insurance could pressure CNA – for example, if pricing softens after a period of rate increases, CNA would need to stay disciplined to avoid underpricing risk. Any signs of undisciplined underwriting (e.g., sharp increases in combined ratio, or rapid growth in new lines) could be a warning sign. So far, CNA has balanced growth and profitability well, but the cyclical nature of insurance means investors should keep an eye on the P&C pricing cycle and claim inflation as forward-looking risks.
Overall, CNA’s risk profile is typical for a large insurer – exposure to insurance losses and financial markets – but the company’s conservative leverage and Loews backing help mitigate some risks. The most salient red flags to watch are reserve developments in long-tail books and the impact of macro conditions (catastrophes, interest rates) on its capital.
Open Questions & Outlook
Looking ahead, there are several open questions and considerations that could shape CNA’s equity story and valuation:
– Sustainability of Special Dividends: Will CNA continue its pattern of sizable special dividends each year? The specials have been funded by robust earnings and excess capital in recent years, but if underwriting margins tighten or if capital needs rise (e.g., due to acquisitions or reserve boosts), management might scale back these extras. Investors will be watching each fourth-quarter earnings announcement for clues – the commitment to annual 5% raises in the regular dividend seems steady, but the continuation of $2.00 specials is less certain. A key question is whether CNA’s core earnings and capital generation will remain strong enough to support returning this level of cash to shareholders without harming its growth or credit profile.
– Underwriting Cycle – Peak or More Room?: The P&C industry has been in a “hard market” phase with rising premiums over the past few years, contributing to CNA’s improved combined ratios and record core income ([4]). An open question is whether CNA is at or near peak underwriting performance. Can the company maintain combined ratios in the low 90s (or better) going forward? If competition intensifies and pricing momentum slows, CNA’s loss ratios could creep up. Management’s challenge will be to retain underwriting discipline – possibly ceding volume if necessary – to avoid eroding profitability. The outcome will influence future earnings growth and, by extension, dividend capacity. Investors should ask if current results are cyclical highs or a new normal achieved through structural improvements. The answer will affect how one values the stock (cyclical low P/E or justified low valuation?).
– Interest Rate Impact and Investment Strategy: With interest rates significantly higher now than a few years ago, CNA stands to earn more on its invested float, which is a tailwind for earnings. The question is how effectively CNA can reinvest at higher yields and whether its investment portfolio has any latent risks. For example, if inflation persists or a recession hits, will CNA face higher-than-expected defaults or downgrades in its bond holdings? Thus far, credit quality in the portfolio appears solid, and higher rates have actually improved the statutory LTC reserve picture ([8]) ([8]). Going forward, will CNA reposition its investments (e.g., to lock in longer durations at attractive yields, or to reduce interest rate sensitivity)? Also, if rates level off or decline, the boost to investment income will fade – how will that affect earnings momentum? This balance between investment yield gains and potential market value swings remains an open element of the outlook.
– Strategic Direction Under New Leadership: With Doug Worman at the helm as CEO (and a new CFO, as Scott Lindquist took over in 2023), it remains to be seen if any strategic shifts are planned. Worman’s background in underwriting might suggest a continued focus on profitable growth in the commercial specialty lines CNA excels in. However, investors might wonder if CNA will address its structural issues: for example, could CNA seek to offload or reinsure more of its long-term care exposure to remove that overhang? Or might CNA attempt to expand into new products or geographies to spur growth (potentially introducing new risks)? Another question is whether Loews and CNA management have interest in share buybacks or float reduction – given the low valuation, buying back the remaining minority shares could be accretive, but so far only small buybacks (~$20 million in 2024) have occurred ([8]). The strategic stance of “steady as she goes” has served CNA well, but any change (or lack thereof) under the new leadership is something to watch.
– Unlocking Value (or Not) for Minority Shareholders: Finally, a broader question is whether CNA’s value will be unlocked for minority shareholders over time. With the stock at ~1× book and a high yield, one might argue CNA is undervalued. However, as noted, the majority ownership by Loews can keep that valuation gap persistent. Loews itself might prefer CNA’s earnings and dividends as a steady contributor and has not indicated any intent to spin-off or sell down its stake. Will this conglomerate structure continue indefinitely? If so, CNA’s stock could remain somewhat under the radar, delivering returns mainly via dividends. Conversely, if Loews’ new CEO or future strategy looked to highlight CNA’s value (for example, by increasing the float or pursuing growth that attracts more investors), there could be upside. This remains speculative – for now, Loews shows every sign of retaining CNA, so minority investors must be content with the dividend stream and slow capital appreciation. The open question is whether the market will eventually rerate CNA higher for its consistent performance, or if it will languish at a discount absent a catalyst.
In conclusion, CNA Financial is a quietly performing insurer with strong dividends, solid underwriting, and cautious financial management. The company’s P&C business is thriving (as suggested by improving combined ratios and premium growth even in challenging markets ([12])), and that success is flowing through to shareholders via a nearly 4% yield plus specials – which is why “priests in Australia & France are thriving” may be a tongue-in-cheek nod to the generous payouts (if one considers income investors as beneficiaries). Still, investors should weigh the discussed risks such as catastrophe exposure and reserve uncertainties. Going forward, the story hinges on CNA’s ability to sustain its operational momentum under new leadership and a changing market environment. With a conservative balance sheet and backing from Loews, CNA has the tools to navigate challenges. The stock’s low valuation and high payout could present an opportunity if the company continues to execute and if the market gains more appreciation for CNA’s steady prosperity. As always, monitoring quarterly results (particularly loss trends and any management guidance on capital return) will be key to answering the open questions around this under-the-radar insurance player.
Sources
- https://reuters.com/business/finance/loews-profit-rises-strong-premiums-investment-income-names-new-ceo-2024-07-29/
- https://loews.com/investors/news/news-details/2021/CNA-Financial-Announces-Third-Quarter-2021-Net-Income-of-0.94-Per-Share-and-Core-Income-of-0.87-Per-Share-11-01-2021/default.aspx
- https://investor-relations.cna.com/news/news-details/2023/CNA-FINANCIAL-ANNOUNCES-Q4-2022-NET-INCOME-OF-0.91-PER-SHARE-AND-CORE-INCOME-OF-1.01-PER-SHARE-FULL-YEAR-2022-NET-INCOME-OF-3.28-PER-SHARE-AND-CORE-INCOME-OF-3.84-PER-SHARE-REGULAR-QUARTERLY-DIVIDEND-INCREASED-5-TO-0.42-PER-SHARE-SPECIAL-DIVIDEND-OF-/default.aspx
- https://sec.gov/Archives/edgar/data/21175/000002117525000004/q42024exhibit991.htm
- https://macrotrends.net/stocks/charts/CNA/cna-financial/dividend-yield-history
- https://nasdaq.com/articles/cna-financial-cna-q4-earnings-revenues-beat-dividend-up
- https://sec.gov/Archives/edgar/data/0000021175/000002117522000012/q4-21exhibit991.htm
- https://sec.gov/Archives/edgar/data/21175/000002117525000008/cna-20241231.htm
- https://panabee.com/news/cna-financial-s-246-payout-ratio-driven-by-special-dividend-in-q1
- https://macrotrends.net/stocks/charts/CNA/cna-financial/debt-equity-ratio
- https://news.ambest.com/newscontent.aspx?altsrc=23&%3Brefnum=243500
- https://reuters.com/business/retail-consumer/loews-third-quarter-profit-jumps-investment-income-boost-2024-11-04/
- https://koyfin.com/company/cna/dividends/
- https://reinsurancene.ws/cna-financial-names-worman-ceo-robusto-transitions-to-exec-chairman/
- https://bloomberg.com/news/articles/2021-05-20/cna-financial-paid-40-million-in-ransom-after-march-cyberattack
For informational purposes only; not investment advice.
